FindTrial
Sign In

Erector Spinae Plane Block in Breast Surgery

Erector Spinae Plane Block in Breast Surgery: A dose finding trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078795
Enrollment
30
Registered
2024-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Drug Volume Change: We will increase or decrease the volume of local anesthetic ropivacaine by 3 ml depending on the response in previous patient till 6 hours of performance of the bl

Sponsors

All India Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All ASA I to ASA III patients undergoing Modified Radical Mastectomy. 2. Average Indian female height (148-160 cm).

Exclusion criteria

Exclusion criteria: 1. Patients under the age of 18. 2. Allergy to local anesthetics. 3. Analgesic treatment taken within 12 h before surgery.

Design outcomes

Primary

MeasureTime frame
The objective of this study is to estimate the MEV90 (Minimum effective volume) of Ropivacaine 0.375% for Erector Spinae Plane Block for patients undergoing breast surgery.Timepoint: just after surgery, 30 min , 1 hour ,2 hour,3 hour,4 hour—

Secondary

MeasureTime frame
To look for satisfaction score in patients with successful blockTimepoint: 6 hours after the performance of block—

Countries

India

Contacts

Public ContactDr Sachin Kumar

All India Institute Of Medical Sciences,New Delhi

docsachin.k@gmail.com9871549343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026